|
Third Harmonic Bio Inc (NASDAQ: THRD) |
|
Third Harmonic Bio Inc
THRD's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Third Harmonic Bio Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Third Harmonic Bio Inc 's net income grew by 91.73 % in IV. Quarter 2024 year on year, above company average,
• More on THRD's Growth
|
|
Third Harmonic Bio Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Third Harmonic Bio Inc PEG ratio is at 0.04
Company is currently trading with Price to Cash flow multiple of 13.35 in trailing twelve-month period. |
Company |
4.78 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.13.
• More on THRD's Valuation
|
|
|
|
|
Third Harmonic Bio Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Third Harmonic Bio Inc PEG ratio is at 0.04
Company is currently trading with Price to Cash flow multiple of 13.35 in trailing twelve-month period. |
Company |
4.78 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.13.
Third Harmonic Bio Inc Price to Book Ratio is at 0.75 lower than Industry Avg. of 77.71. and higher than S&P 500 Avg. of 0.01
• More on THRD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com